Tyto Insights for Eardrum Bulging Detection
Paid
Regulatory Status Disclosed
Overview
Tyto Insights for Eardrum Bulging Detection is an AI-powered software feature designed to assist healthcare providers in detecting eardrum bulging during otoscopic examinations. This tool is part of TytoCare’s broader virtual care platform, which includes a handheld, all-in-one device for comprehensive remote medical exams. The AI analyzes otoscopic video recordings to identify eardrum bulging, a common sign in conditions like Acute Otitis Media. It is intended for use in patients aged six months and older and provides results as a clinical support tool to aid in diagnosis and treatment decisions, potentially reducing unnecessary antibiotic use and delayed treatment. The TytoCare platform aims to bridge gaps in healthcare delivery by enabling accurate and convenient remote physical exams, replicating in-clinic experiences from the comfort of home.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered eardrum bulging detection
- Analyzes otoscopic video recordings
- Clinical decision support tool for healthcare providers
- Patient insights on ear exams (via Smart Checkup)
- Compatible with TytoCare's digital otoscope
- Aids in diagnosing ear-related conditions (e.g., Acute Otitis Media)
- Reduces unnecessary antibiotic usage
- Reduces delayed treatment
- Supports remote physical examinations
- Secure and encrypted data transmission
Use Cases
- Remote diagnosis of ear infections
- Supporting virtual primary care visits
- Enhancing telehealth consultations with objective ear exam data
- Reducing in-person visits for ear-related concerns
- Pediatric ear exam assessment
- Clinical support in urgent care and rural clinics
Details
| Category | Clinical Decision Support & Reference, Telehealth & Virtual Care |
| Pricing |
Paid
|
| Deployment | Cloud-based (web-based AI-enabled software) with a compatible handheld device and mobile app. |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Cleared AI-estimated Tyto Insights for Eardrum Bulging Detection received FDA De Novo classification on April 27, 2026, establishing a new regulatory category for an "ear, nose, and throat image analyzer." The TytoCare Stethoscope is FDA cleared, and other TytoCare devices comply with FDA requirements. TytoCare has also received FDA clearances for AI-powered wheeze detection (2023), crackle detection (2024), and rhonchi detection (2025). |
| Integrations | |
| EHR | Not specified |
| Specialties | Family Medicine, Otolaryngology (ENT), Pediatrics |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Tyto Insights for Eardrum Bulging Detection
Press & Coverage
Tech News Podcast
TytoCare Announces FDA De Novo Classification for AI Eardrum Analysis
TytoCare received FDA De Novo classification for its Tyto Insights for Eardrum Bulging Detection software on April 27, 2026, marking a significant advancement in AI-assisted diagnostics for remote ear exams. This Class II medical device analyzes video recordings from TytoCare's digital otoscope for patients aged six months and older, but does not provide a diagnosis and requires interpretation by a healthcare provider.
2026-04
Innolitics
The First AI Otoscope: What TytoCare's De Novo Means for AI in ENT - Innolitics
On April 27, 2026, TytoCare announced the FDA granted a De Novo classification for Tyto Insights for Eardrum Bulging Detection, making it the first AI-powered eardrum analysis software to clear U.S. regulatory hurdles. This article delves into the specifics of the De Novo authorization, the reasons behind the slow adoption of AI/ML in ENT, and the implications for future over-the-counter diagnostic-aid devices.
2026-04
accessdata.fda.gov
Device Classification Under Section 513(f)(2)(De Novo) - accessdata.fda.gov
This official FDA document details the De Novo classification for Tyto Insights for Eardrum Bulging Detection, granted on March 17, 2026, to Tyto Care, Ltd. The device is classified under regulation number 874.4775 and product code SHL, falling under the Ear, Nose & Throat advisory committee.
2026-03
Innolitics
March 2026: 24 AI/ML SaMD Clearances in 31 Days - Innolitics
Tyto Care's Tyto Insights for Eardrum Bulging Detection was the sole De Novo clearance in March 2026, notable for being cleared on its first submission due to the lack of a predicate for pediatric otoscopy AI. This highlights a regulatory gap for pediatric-specific eardrum tools and suggests that De Novo may be a viable path for genuine novelty in underserved subpopulations.
2026-05
Innolitics
21 CFR 874.4775 u2014 Ear, Nose, And Throat Image Analyzer - Innolitics
The FDA has classified Tyto Insights for Eardrum Bulging Detection as a Class II medical device, establishing special controls to ensure its safety and effectiveness. This web-based AI-enabled software is intended for over-the-counter use to automatically detect eardrum bulging in otoscopic video recordings from compatible devices in patients aged six months and older, but it is not for diagnosis and requires a healthcare provider's interpretation.
2026-03
FDA
Artificial Intelligence-Enabled Medical Devices - FDA
The FDA's list of Artificial Intelligence-Enabled Medical Devices includes Tyto Insights for Eardrum Bulging Detection by Tyto Care, Ltd., with a decision date of March 17, 2026, under the Ear Nose & Throat panel and product code SHL. This resource provides transparency for healthcare providers and patients regarding authorized AI-enabled medical devices in the U.S. market.
2026-03
Straits Research
Cerumen Removal Market Size, Share, Growth, Analysis, Report, 2034 - Straits Research
In March 2026, Tyto Care received FDA De Novo authorization for its Tyto Insights for Eardrum Bulging Detection technology, which is expected to strengthen the role of digital ear examination platforms in remote ear health management. This approval supports broader adoption of connected ear diagnostic solutions that can assist healthcare providers in evaluating ear conditions, including those associated with cerumen buildup.
2026-07
Alfabeta CRO
u7f8eu570bFDAu6838u51c6Tyto Insights for Eardrum Bulging Detectionu4e0au5e02 - Alfabeta CRO
The FDA approved Tyto Insights for Eardrum Bulging Detection for market release, highlighting the growing trend of AI medical software extending from image interpretation to emergency and wound care. This approval signifies a move towards integrating AI tools that provide objective, non-invasive, and repeatable assessment information to aid healthcare professionals in their diagnostic and treatment decisions.
2026-07
Videos
Product demos, reviews, and walkthroughs for Tyto Insights for Eardrum Bulging Detection.
The Palace of Darkened Windows ud83cudff0u2728| Mary Hastings Bradley
Storytime Haven
Frequently Asked Questions
Tyto Insights is designed to seamlessly integrate with your current TytoCare examination process. After a TytoCare ear exam, the AI algorithm automatically analyzes the captured images and provides a bulging detection assessment within the TytoCare platform, appearing alongside other exam data. This allows for quick review and incorporation into your diagnostic decision-making without significant workflow disruption.
Tyto Insights has undergone rigorous validation studies, demonstrating high sensitivity and specificity in detecting eardrum bulging. The AI model was trained on a diverse dataset of clinically confirmed cases and has been shown to assist in identifying bulging with a strong correlation to physician diagnoses.
While Tyto Insights is intuitive to use, a brief orientation on interpreting the AI-generated insights within the TytoCare platform is recommended. TytoCare provides educational resources and support to ensure physicians and their staff are comfortable and proficient in leveraging the tool for optimal clinical decision support.
Tyto Insights serves as a powerful adjunctive tool to enhance the accuracy and efficiency of eardrum bulging detection, particularly in telehealth settings. It is not intended to replace a comprehensive in-person examination when clinically indicated, but rather to provide valuable data to support clinical judgment and guide further management.
Tyto Insights is a decision support tool and its output should always be considered in conjunction with the full clinical picture, patient history, and other diagnostic findings. Limitations may include cases with excessive cerumen obstruction, very subtle bulging, or unusual anatomical variations that could impact image quality or AI interpretation. Clinical judgment remains paramount.
The pricing model for Tyto Insights is typically structured as an add-on feature to existing TytoCare subscriptions. Specific details regarding pricing, potential insurance reimbursement, and bundling options can be obtained directly from TytoCare sales representatives, as these may vary based on your current contract and regional policies.
Suggest an Edit →
| Last Verified: 2026-08-19 | First Added: 2026-08-19
Investors who backed Tyto Insights for Eardrum Bulging Detection
Funded through the company that built this tool.
Tiger Global Management
VC
T1
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services
Triventures
VC
AI
T3
AI/ML in Healthcare
Digital Health
ALIVE Israel HealthTech Fund
Solo Angel
AI
T3
Digital Health
Medical Devices / MedTech
Pitango HealthTech
VC
AI
T1
AI/ML in Healthcare
Digital Health
Marius Nacht
Solo Angel
AI
T3
AI/ML in Healthcare
Biotech